British biomedical firm, ViraCorp, has joined forces with leading pharmaceutical company, Incepta, to develop a Covid-19 vaccine, which can be administered via one's nose.
British biomedical firm ViraCorp has joined forces with leading Bangladeshi pharmaceutical company Incepta to develop needle-free Covid-19 vaccine, which uses state-of-the-art intra-nasal technology.
Power cuts in China have started to affect Bangladesh’s garment and other industries reliant on raw material supply from the country, a blow that could derail the recovery of the economy from the coronavirus pandemic.